MedPath

江苏鹏鹞药业有限公司

Ownership
-
Established
2002-01-21
Employees
-
Market Cap
-
Website
https://www.pengyaopharm.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

203

NMPA:203

Drug Approvals

Netilmicin Sulfate Injection

Product Name
硫酸奈替米星注射液
Approval Number
国药准字H20057088
Approval Date
Aug 22, 2022
NMPA

Glucose and Sodium Chloride Injection

Product Name
葡萄糖氯化钠注射液
Approval Number
国药准字H32023570
Approval Date
Apr 21, 2021
NMPA

Glucose and Sodium Chloride Injection

Product Name
葡萄糖氯化钠注射液
Approval Number
国药准字H32023566
Approval Date
Apr 21, 2021
NMPA

Glucose and Sodium Chloride Injection

Product Name
葡萄糖氯化钠注射液
Approval Number
国药准字H32023564
Approval Date
Apr 21, 2021
NMPA

Glucose and Sodium Chloride Injection

Product Name
葡萄糖氯化钠注射液
Approval Number
国药准字H32023568
Approval Date
Apr 21, 2021
NMPA

Glucose and Sodium Chloride Injection

Product Name
葡萄糖氯化钠注射液
Approval Number
国药准字H32023569
Approval Date
Apr 21, 2021
NMPA

Rifampicin Capsules

Product Name
利福平胶囊
Approval Number
国药准字H32021015
Approval Date
Apr 21, 2021
NMPA

Glucose and Sodium Chloride Injection

Product Name
葡萄糖氯化钠注射液
Approval Number
国药准字H32023567
Approval Date
Apr 21, 2021
NMPA

Glucose and Sodium Chloride Injection

Product Name
葡萄糖氯化钠注射液
Approval Number
国药准字H32023565
Approval Date
Apr 21, 2021
NMPA

Amlodipin Besylate Tablets

Product Name
苯磺酸氨氯地平片
Approval Number
国药准字H20065943
Approval Date
Apr 20, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 21
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.